Bank of New York Mellon »

Compass Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-09-30 $427k 232k 1.84
2024-06-30 $284k 284k 1.00
2024-03-31 $500k 253k 1.98
2023-12-31 $423k 271k 1.56
2023-09-30 $537k 273k 1.97
2023-06-30 $863k 271k 3.18
2023-03-31 $129k 39k 3.27
2022-12-31 $198k 39k 5.03
2022-09-30 $55k 24k 2.27